174 related articles for article (PubMed ID: 36148733)
1. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
[TBL] [Abstract][Full Text] [Related]
2. The mineral dust-induced gene,
Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
[TBL] [Abstract][Full Text] [Related]
3. PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.
Wu K; Xu L; Cheng L
Comput Math Methods Med; 2021; 2021():5542485. PubMed ID: 33968158
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin promotes lung adenocarcinoma cell proliferation, migration and invasion by activating the EGFR/MAPK signaling pathway.
Li M; Wu R; Zhu D; Wang L; Liu S; Wang R; Deng C; Zhang S; Chen M; Lu R; Zhu H; Mo M; Luo Z
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165929
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-140-3p represses the proliferation, migration, invasion and angiogenesis of lung adenocarcinoma cells via targeting TYMS (thymidylate synthetase).
Wan S; Liu Z; Chen Y; Mai Z; Jiang M; Di Q; Sun B
Bioengineered; 2021 Dec; 12(2):11959-11977. PubMed ID: 34818974
[TBL] [Abstract][Full Text] [Related]
6. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway.
Zhang H; Cao Y; Tang J; Wang R
Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221
[TBL] [Abstract][Full Text] [Related]
7. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
8. TIMELESS promotes the proliferation and migration of lung adenocarcinoma cells by activating EGFR through AMPK and SPHK1 regulation.
Yin H; Wang Z; Wang D; Nuer M; Han M; Ren P; Ma S; Lin C; Chen J; Xian H; Ai D; Li X; Ma S; Lin Z; Pan Y
Eur J Pharmacol; 2023 Sep; 955():175883. PubMed ID: 37433364
[TBL] [Abstract][Full Text] [Related]
9. TMEM9 promotes lung adenocarcinoma progression via activating the MEK/ERK/STAT3 pathway to induce VEGF expression.
Wang Z; Zhao P; Tian K; Qiao Z; Dong H; Li J; Guan Z; Su H; Song Y; Ma X
Cell Death Dis; 2024 Apr; 15(4):295. PubMed ID: 38664392
[TBL] [Abstract][Full Text] [Related]
10. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway.
Qian S; Wang F; Liao W; Liu J
Neoplasma; 2024 Feb; 71(1):22-36. PubMed ID: 38506034
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma.
Liu L; Bi N; Wu L; Ding X; Men Y; Zhou W; Li L; Zhang W; Shi S; Song Y; Wang L
Mol Cancer; 2017 Feb; 16(1):50. PubMed ID: 28241836
[TBL] [Abstract][Full Text] [Related]
12. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer.
Zhan R; Yu H; Zhang G; Ding Q; Li H; Li X; Tang X
Front Biosci (Landmark Ed); 2024 May; 29(5):189. PubMed ID: 38812317
[TBL] [Abstract][Full Text] [Related]
13. Sec61γ is a vital protein in the endoplasmic reticulum membrane promoting tumor metastasis and invasion in lung adenocarcinoma.
Xu S; Li X; Geng J; Cao Y; Yu Y; Qi L
Br J Cancer; 2023 Apr; 128(8):1478-1490. PubMed ID: 36759724
[TBL] [Abstract][Full Text] [Related]
14. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
[TBL] [Abstract][Full Text] [Related]
15. Mammalian Eps15 homology domain 1 potentiates angiogenesis of non-small cell lung cancer by regulating β2AR signaling.
Wang T; Xing Y; Meng Q; Lu H; Liu W; Yan S; Song Y; Xu X; Huang J; Cui Y; Jia D; Cai L
J Exp Clin Cancer Res; 2019 Apr; 38(1):174. PubMed ID: 31023336
[TBL] [Abstract][Full Text] [Related]
16. The impact of PRDX4 and the EGFR mutation status on cellular proliferation in lung adenocarcinoma.
Mizutani K; Guo X; Shioya A; Zhang J; Zheng J; Kurose N; Ishibashi H; Motono N; Uramoto H; Yamada S
Int J Med Sci; 2019; 16(9):1199-1206. PubMed ID: 31588184
[No Abstract] [Full Text] [Related]
17. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y
IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA linc00665 interacts with YB-1 and promotes angiogenesis in lung adenocarcinoma.
Cong Z; Diao Y; Li X; Jiang Z; Xu Y; Zhou H; Qiang Y; Wu H; Shen Y
Biochem Biophys Res Commun; 2020 Jun; 527(2):545-552. PubMed ID: 32423800
[TBL] [Abstract][Full Text] [Related]
20. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
Ma S; Wang X; Zhang Z; Liu D
Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
